Clovis Oncology, Inc. Gains 30.43%

Mon, Sep 12, 2022 at 07:39 PM
Clovis Oncology, Inc. Gains 30.43%

Clovis Oncology, Inc. (CLVS:NASDAQ) soared at $1.5, representing a gain of 30.4%. On Mon, Sep 12, 2022, CLVS:NASDAQ touched a New 2-Week High of $1.5. The stock got featured on our News Catalysts scanner on Mon, Sep 12, 2022 at 12:32 PM in the 'BIOTECH' category. From Mon, Aug 29, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days

The stock spiked on Fri, Jul 08, 2022 at $3.25 with a volume of 104M+.

About Clovis Oncology, Inc. (CLVS:NASDAQ)

Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.